Research and Developments

Page 19 of 19« First...10...1516171819

May 7, 2000

Glucocorticoids and Secondary Stress as Combined Causes of Chronic Central Serous Chorioretinopathy in Type A People

Posted in: Research and Developments

by Dan Roberts, Director Macular Degeneration Support, Inc. May 7, 2000 Introduction Central serous chorioretinopathy (CSC), also known as central serous retinopathy (CSR), is characterized by a serous detachment of the retina which often occurs in middle-aged, caucasian males who exhibit Type A behavior patterns. Chronic CSC may result from the biological effects of glucocorticoids
read more »

September 27, 1999

New Drug May Halt Vision Loss

Posted in: Latest News, Research and Developments

by Dan Roberts September 27, 1999 A new anti-angiogenesis agent called PKC 412 has halted abnormal growth of retinal blood vessels which cause vision loss in macular degeneration and diabetic retinopathy. It is made by Novartis Ltd. Pharmaceuticals, and much of the lab work is being done by Dr. Peter Campochiaro, professor of ophthalmology and
read more »

Page 19 of 19« First...10...1516171819

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann